Compounds > efavirenz

efavirenz and Abnormalities, Drug-Induced

efavirenz has been researched along with Abnormalities, Drug-Induced in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (20.00)18.2507
2000's3 (15.00)29.6817
2010's13 (65.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antony, J; Ashoor, HM; Blondal, E; Finkelstein, Y; Ghassemi, M; Gough, K; Hemmelgarn, BR; Hutton, B; Ivory, JD; Khan, PA; Lillie, E; Straus, SE; Tricco, AC; Vafaei, A; Veroniki, AA1
Barfield, W; Honein, MA; Rasmussen, SA1
Favarato, G; Gayet-Ageron, A; Martinez de Tejada, B; Thorne, C; Winterfeld, U1
Abrams, EJ; Tsague, L1
Andrieux-Meyer, I; Calmy, A; Ford, N; Mofenson, L; Renaud, F; Shaffer, N; Shubber, Z; Vitoria, M1
Bera, E; Chacko, S; Majeke, B; McCausland, K; Mgudlwa, B; Nonkwelo, R1
Calmy, A; Ford, N; Frigati, L; Kranzer, K; Medu, L; Mills, EJ; Mofenson, L1
Cotich, KL; Freedberg, KA; Goldie, SJ; Hsu, HE; Losina, E; Lu, Z; Rydzak, CE; Sax, PE; Walensky, RP; Wang, B1
Calmy, A; Ford, N; Mofenson, L1
Anglaret, X; Chu, J; Danel, C; Eholié, S; Freedberg, KA; Gabillard, D; Hsu, HE; Moh, R; Ouattara, EN; Walensky, RP; Wong, AY1
Mofenson, LM; Nachega, JB; Uthman, O1
Calmy, A; Ford, N1
Shanske, AL1
Mofenson, LM1
Baker, R1
Cadman, J1

Reviews

5 review(s) available for efavirenz and Abnormalities, Drug-Induced

ArticleYear
Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Congenital Abnormalities; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Network Meta-Analysis; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Stavudine; Stillbirth; Zidovudine

2018
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    AIDS (London, England), 2014, Volume: 28 Suppl 2

    Topics: Abnormalities, Drug-Induced; Alkynes; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Reverse Transcriptase Inhibitors; Treatment Outcome

2014
Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts.
    AIDS (London, England), 2010, Jun-19, Volume: 24, Issue:10

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Risk Factors

2010
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    AIDS (London, England), 2011, Nov-28, Volume: 25, Issue:18

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Incidence; Neural Tube Defects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Risk Factors; Treatment Outcome

2011
Bilateral oblique facial clefts and extremity anomaly in an infant after intrauterine efavirenz exposure and review of its teratogenic risk.
    AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14

    Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child of Impaired Parents; Cleft Palate; Craniofacial Dysostosis; Cyclopropanes; Eye Abnormalities; Female; Humans; Imaging, Three-Dimensional; Infant; Infant, Newborn; Maxillofacial Abnormalities; Pregnancy; Prenatal Exposure Delayed Effects; Radiography; Teratogens

2012

Other Studies

15 other study(ies) available for efavirenz and Abnormalities, Drug-Induced

ArticleYear
Protecting Mothers and Babies - A Delicate Balancing Act.
    The New England journal of medicine, 2018, Sep-06, Volume: 379, Issue:10

    Topics: Abnormalities, Drug-Induced; Alkynes; Animals; Anti-Retroviral Agents; Benzoxazines; Congenital Abnormalities; Cyclopropanes; Female; Fetus; Heterocyclic Compounds, 3-Ring; Humans; Infant, Newborn; Neural Tube Defects; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pyridones

2018
Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis.
    Journal of acquired immune deficiency syndromes (1999), 2019, 03-01, Volume: 80, Issue:3

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Female; Fertilization; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Stillbirth

2019
Commentary: Antiretroviral treatment for pregnant and breastfeeding women--the shifting paradigm.
    AIDS (London, England), 2014, Volume: 28 Suppl 2

    Topics: Abnormalities, Drug-Induced; Alkynes; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors

2014
Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
    AIDS (London, England), 2010, Jan-16, Volume: 24, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Prenatal Exposure Delayed Effects; Prevalence; Prospective Studies; South Africa; Ultrasonography, Prenatal

2010
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.
    HIV medicine, 2011, Volume: 12, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Life Expectancy; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk Assessment; Risk Factors; Teratogens; United States

2011
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.
    AIDS (London, England), 2012, Mar-13, Volume: 26, Issue:5

    Topics: Abnormalities, Drug-Induced; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Computer Simulation; Cote d'Ivoire; Cyclopropanes; Female; HIV Infections; Humans; Nevirapine; Prognosis; Risk Assessment; Survival Rate

2012
Safety and effectiveness of efavirenz versus nevirapine-based regimens in resource-limited settings: evidence, clinical practice and modelling projections.
    AIDS (London, England), 2012, Mar-13, Volume: 26, Issue:5

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Computer Simulation; Cyclopropanes; Female; HIV Infections; Humans; Nevirapine

2012
Efavirenz is not a known teratogen.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:9

    Topics: Abnormalities, Drug-Induced; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Female; Humans; Maternal Exposure; Pregnancy; Prevalence; Risk Factors

2012
Birth defect in baby born to efavirenz-user.
    TreatmentUpdate, 2002, Volume: 14, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Humans; Infant, Newborn; Oxazines; Reverse Transcriptase Inhibitors; Viral Load

2002
Efavirenz reclassified as FDA pregnancy category D.
    AIDS clinical care, 2005, Volume: 17, Issue:2

    Topics: Abnormalities, Drug-Induced; Alkynes; Benzoxazines; Cyclopropanes; Female; Fetus; HIV Infections; Humans; Oxazines; Pregnancy; Reverse Transcriptase Inhibitors

2005
Pregnancy category change for efavirenz.
    AIDS patient care and STDs, 2005, Volume: 19, Issue:6

    Topics: Abnormalities, Drug-Induced; Alkynes; Benzoxazines; Cyclopropanes; Dandy-Walker Syndrome; Female; Fetal Monitoring; Follow-Up Studies; HIV Infections; Humans; Infant, Newborn; Meningomyelocele; Monitoring, Physiologic; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Retrospective Studies

2005
Treatment for AIDS.
    The Journal of the American Osteopathic Association, 1998, Volume: 98, Issue:10

    Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Benzoxazines; Child; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Drug Approval; Female; HIV Infections; Humans; Infant, Newborn; Male; Oxazines; Pregnancy; Reverse Transcriptase Inhibitors; United States

1998
Safety alert issued on efavirenz (Sustiva).
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998

    Topics: Abnormalities, Drug-Induced; Alkynes; Anencephaly; Animals; Benzoxazines; Cleft Palate; Cyclopropanes; Eye; Haplorhini; HIV Infections; Oxazines; Pregnancy; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration

1998
Notice on efavirenz and pregnancy.
    AIDS treatment news, 1998, Apr-03, Issue:No 292

    Topics: Abnormalities, Drug-Induced; Alkynes; Animals; Benzoxazines; Cyclopropanes; Drugs, Investigational; Female; Haplorhini; HIV Infections; Maternal-Fetal Exchange; Oxazines; Pregnancy; Reverse Transcriptase Inhibitors

1998
Efavirenz pregnancy warning.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1998, Volume: 12, Issue:3

    Topics: Abnormalities, Drug-Induced; Alkynes; Animals; Benzoxazines; Cyclopropanes; Female; Haplorhini; HIV Infections; Humans; Male; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors

1998